Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Recruiting · NCT04900818 · Registry updated 2026-03-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, biliary tract disorder, digestive system disorder, digestive system neoplasm, esophageal adenocarcinoma, gastric cancer, gastric neoplasm, metastatic malignant neoplasm, neoplasm, stomach disorder | Recruiting | Phase 1 | 2026-03-05 | NCT04900818 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| I-Mab Biopharma US Limited | 2 |
21 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.